Pamrevlumab

Pamrevlumab (INN;^[1] development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.^[2]

Pamrevlumab

Monoclonal antibody
Type	?
Source	Human
Target	CTGF
Clinical data
Other names	FG-3019
ATC code	none
Identifiers
CAS Number	946415-13-0
ChemSpider	none
UNII	QS5F6VTS0O
KEGG	D10969
Chemical and physical data
Formula	C6492H10018N1718O2086S48
Molar mass	147050.38 g·mol−1

This drug was developed by FibroGen, Inc.^[3]